Top News

Vaccine alliance, Serum agree extra 100 million COVID-19 dose deal for poorer countries

A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (COVID-19) at its laboratory in Pune, India, May 18, 2020. Picture taken May 18, 2020. REUTERS/Euan Rocha/Files

LONDON (Reuters) - The GAVI vaccine alliance said on Tuesday it had agreed a new collaboration with Indian pharmaceutical company Serum Institute that will make an extra 100 million doses of COVID-19 vaccines available for low and middle income countries.

The additional doses bring the total COVID-19 vaccines to be delivered by the Serum partnership to up to 200 million doses, GAVI said in a statement. They will be priced at a maximum of $3 per dose.

Reporting by Kate Kelland; editing by Jason Neely